Abu Dhabi’s Mubadala Investment Company buys KELIX bio acquisitionNorth Africaprivate equity Tagspharmaceuticalssecondary buyout 25/03/2024 Sign-up to receive altAfrica's content for two weeks by registering here with a business email address. 25/03/2024 More articles ― private equityVitruvian acquires Africa Specialty Risks from Helios Investment Partners controlling stakeSecondary buyout for ADEMAT as Amethis succeeds SPE Capital DFISPE Capital leads consortium to back Orchidia Pharmaceutical Industries
